Primary Care Enhanced Services
Overview
Summary, notice description and lot information
The NHS Lincolnshire Integrated Care Board is in the process of awarding a contract for Primary Care Enhanced Services, including phlebotomy, treatment room, and specialised drug monitoring, among other services. This procurement falls under the industry category of general-practitioner services and is intended to serve the UKF3 region. The procurement method is limited, with no prior call for competition, under the Provider Selection Regime (PSR) regulations, and aims to award the contract starting from 1st April 2025 to 31st March 2026, valued at £35,308.
The procurement is at the award stage with the intention to formally conclude by 10 September 2025, following a standstill period where representations can be made. This tender represents significant business growth opportunities, particularly for existing health service providers with expertise in general-practitioner services. SMEs like The Sutterton Surgery, currently involved in the procurement, illustrate the kind of well-suited businesses capable of fulfilling the contract's requirements.
With a focus on quality, innovation, integration, and social value, businesses proficient in delivering efficient, sustainable healthcare services stand to gain. Moreover, this contract allows for the continuity and enhancement of existing services, favouring established providers with a proven track record under the PSR criteria.
NHS Lincolnshire ICB is intending to utilise direct award process C of the Provider Selection Regime regulations to award a contract for the provision of: - Primary Care Enhanced Services, including: - Phlebotomy - Treatment Room - Leg Ulcer - Pessaries - Warfarin - DOAC, Gonadorelins (Zoladex) - Specialised Drug Monitoring - Safeguarding
NHS Lincolnshire ICB is intending to utilise direct award process C of the Provider Selection Regime regulations to award a contract for the provision of: - Primary Care Enhanced Services, including: - Phlebotomy - Treatment Room - Leg Ulcer - Pessaries - Warfarin - DOAC, Gonadorelins (Zoladex) - Specialised Drug Monitoring - Safeguarding The contract duration is from 1st April 2025 to 31st March 2026 and the expected value of the activity for the lifetime of the contract is PS35,308. The provider is an existing provider and the services are existing services.
Procurement Classification
Notice type, method, and CPV codes
Contract Values
Financial information and value estimates
Contract duration information not available.
Key Dates
Publication, submission, and award timeline
Notice Status
Current status of tender, lots, awards, and contracts
Contracting Authority
Buyer organisation and contact details
Awarded Supplier
Supplier who was awarded this contract
Documents & Links
External resources and data downloads
The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector.
Need help with your tender submission?
Our expert team can help you prepare a winning bid. Get professional support from CareSync Experts.
Get in touch with our team at Care Sync Experts today for a consultation.
Email: hello@caresyncexperts.co.uk
Phone: 0333 577 0877
Contact UsBidding for contracts like this
Other tenders in North Kesteven
- Lung Cancer Screening Programme on behalf of NHS Lincolnshire ICB in North Kesteven
- Environmental Controls - Direct Award Process C in North Kesteven
- Specialist Neighbourhood Nurses Services in North Kesteven
- Musculoskeletal and Spinal Service in North Kesteven
- Market Engagement - NHS Lincolnshire ICB - Night Light Cafes Service in North Kesteven
- GP Practice Medical Cover for Hospice in the Hospital in North Kesteven